Literature DB >> 20687892

The role of nuclear factor-kappaB in inflammatory lung disease.

Abbas Ali Imanifooladi1, Samaneh Yazdani, Mohammad Reza Nourani.   

Abstract

Nuclear factor-kappaB (NF-kappaB) is one of the most important transcription factors; it has a key role in inflammatory and immune responses, cell adhesion, developmental signals, and anti-apoptosis process. Inflammatory lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. In this review, we highlight the role of NF-kappaB in inflammatory lung disease, the strategies which block the activation of NF-kappaB, and the therapeutic approaches to treating inflammatory lung disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687892     DOI: 10.2174/187152810792231904

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  22 in total

1.  Sesamin attenuates allergic airway inflammation through the suppression of nuclear factor-kappa B activation.

Authors:  Liangchang Li; Hongmei Piao; Mingyu Zheng; Zhewu Jin; Liguang Zhao; Guanghai Yan
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

Review 2.  Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.

Authors:  Jintao Zhang; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

3.  Glycyrrhizic Acid Prevents Sepsis-Induced Acute Lung Injury and Mortality in Rats.

Authors:  Hongyu Zhao; Min Zhao; Yu Wang; Fengchun Li; Zhigang Zhang
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

4.  NF-κB1 promoter-94ins/delATTG polymorphisms correlate with the acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Xun Meng; Shao-Qiang Zheng; Jin-Hong Wang; Tao Zhang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

5.  PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases.

Authors:  Yongchun Shen; Lei Chen; Tao Wang; Fuqiang Wen
Journal:  PPAR Res       Date:  2012-06-17       Impact factor: 4.964

6.  Protective Effect of the Fruit Hull of Gleditsia sinensis on LPS-Induced Acute Lung Injury Is Associated with Nrf2 Activation.

Authors:  Jun-Young Choi; Min Jung Kwun; Kyun Ha Kim; Ji Hyo Lyu; Chang Woo Han; Han-Sol Jeong; Ki-Tae Ha; Hee-Jae Jung; Beom-Joon Lee; Ruxana T Sadikot; John W Christman; Sung-Ki Jung; Myungsoo Joo
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-14       Impact factor: 2.629

7.  Regulation of Proinflammatory Mediators via NF-κB and p38 MAPK-Dependent Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated from Korea Lonicera japonica THUNB.

Authors:  Kwang-Il Park; Sang-Rim Kang; Hyeon-Soo Park; Do Hoon Lee; Arulkumar Nagappan; Jin A Kim; Sung Chul Shin; Eun Hee Kim; Won Sup Lee; Hyon-Jong Chung; Su Jin An; Gon Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

8.  Probiotic as a novel treatment strategy against liver disease.

Authors:  Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Mohammad Reza Nourani; Soghra Khani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-02-25       Impact factor: 0.660

9.  Therapeutic effect of C-phycocyanin extracted from blue green algae in a rat model of acute lung injury induced by lipopolysaccharide.

Authors:  Pak-On Leung; Hao-Hsien Lee; Yu-Chien Kung; Ming-Fan Tsai; Tz-Chong Chou
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

10.  Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.

Authors:  Devon J Shedlock; Colleen Tingey; Lavanya Mahadevan; Natalie Hutnick; Emma L Reuschel; Sagar Kudchodkar; Seleeke Flingai; Jenny Yan; Joseph J Kim; Kenneth E Ugen; David B Weiner; Kar Muthumani
Journal:  Vaccines (Basel)       Date:  2014-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.